ArticleIntestinal Failure (New York, N.Y.)
Intestinal failure in kaposiform hemangioendothelioma successfully resolved with medical therapy and nearly fat-free oral feeding: A novel case report.
Article in Intestinal Failure (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kaposiform hemangioendothelioma and kaposiform lymphangiomatosis (KHE/KLA) are rare, non-malignant lymphovascular anomalies often complicated by Kasabach-Merritt phenomenon (KMP). Morbidity and mortality are high. There are no prior reports of the dietary management in these disorders. Case report: A 2-month-old female presented with hemorrhagic ascites, abdominal compartment syndrome, and severe KMP secondary to extensive retroperitoneal and intestinal KHE/KLA. Following emergent surgical management for abdominal decompression and diverting ileostomy, medical and nutritional therapy with steroids, vincristine, sirolimus, and parenteral nutrition were employed for management. After maintaining a near fat-free enteral diet supplemented with intravenous lipid therapy in the outpatient setting, she underwent successful ileostomy takedown 18 months after initial diagnosis without the need for intestinal resection and maintenance of adequate growth. Conclusion: This case underscores the value of clinical and pathology-guided diagnosis, coordinated medical therapy, and dietary fat restriction for achieving intestinal autonomy and preserving bowel length in intra-abdominal KHE/KLA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.